H3

ClouDr Group LtdFRA ClouDr Stock Report

Last reporting period 30 Jun, 2022

Updated 13 Nov, 2024

Last price

Market cap $B

0.082

Micro

Exchange

XFRA - Deutsche Boerse AG

H3L.F Stock Analysis

H3

Uncovered

ClouDr Group Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.082

Dividend yield

Shares outstanding

587.04 B

ClouDr Group Ltd. operates as an investment holding company. The company is headquartered in Hangzhou, Zhejiang and currently employs 1,435 full-time employees. The company went IPO on 2022-07-06. The firm provides medical supplies and software-as-a-service (SaaS) products to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultations and prescriptions to patients. The firm's product portfolio consists of three major product or service categories. The in-hospital solution mainly includes hospital supplies sales, hospital SaaS and digital marketing services. The pharmacy solution mainly includes pharmacy supplies sales and pharmacy SaaS. The individual chronic condition management solution and others mainly include chronic condition products, premium membership services, as well as insurance brokerage services, advertisement agent services and others.

View Section: Eyestock Rating